<DOC>
	<DOCNO>NCT01691313</DOCNO>
	<brief_summary>Evaluate safety efficacy single oral dose vanoxerine compare placebo , dose modification manner , conversion symptomatic atrial fibrillation ( a-fib ) flutter recent onset normal sinus rhythm .</brief_summary>
	<brief_title>Safety Efficacy Vanoxerine Conversion Atrial Fibrillation Flutter Normal Sinus Rhythm</brief_title>
	<detailed_description>Vanoxerine important antiarrhythmic property may prove effective convert AF/AFL sinus rhythm subject history AF . This prospective , randomize , double-blinded , placebo-controlled , dose-modifying study subject symptomatic AF AFL 3 hour less 7 day date symptom , AF/AFL document ECG time study drug administration , satisfy inclusion exclusion criterion . The primary objective trial evaluate safety efficacy single oral dose vanoxerine compare placebo follow oral administration .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Atrial Flutter</mesh_term>
	<mesh_term>Vanoxerine</mesh_term>
	<criteria>provide write informed consent , male female 18 year age great ; woman child bear potential must use adequate contraception symptomatic AF/AFL 3 hour less 7 day ( 168 hour ) , date symptom AF/AFL document ECG start study drug administration Systolic blood pressure &lt; 100 mmHg . Average heart rate &lt; 50 bpm . Average QTcF ( Fridericia correction ) &gt; 440 ms. Average QRS interval &gt; 140 m . Paced atrial ventricular rhythm ECG . Serum potassium &lt; 3.5 meq/L ( may correct prior randomization ) . Received another intravenous Class I Class III antiarrhythmic drug within prior 3 day . receive amiodarone ( oral IV ) prior 3 month . Clinical evidence history acute coronary syndrome within 30 day prior randomization . Aortic stenosis aortic valve area equal le 1.0 cm2 . Rheumatic mitral stenosis valve area &lt; 1.5 cm2 . Untreated hyperthyroidism . Acute pericarditis . AF/AFL result surgery within last 7 day History fail electrical cardioversion History polymorphic ventricular tachycardia ( PVT , e.g . torsades de pointes ) . History family history long QT syndrome . History ventricular tachycardia require drug device therapy . History NYHA Heart Failure Class 3 4 recent ( within 1 month ) onset heart failure relate rapid ventricular response AF . Ejection fraction ( EF ) 35 % less .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>vanoxerine</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>atrial flutter</keyword>
	<keyword>a-fib</keyword>
</DOC>